» Articles » PMID: 35187038

Relationship Between Nutritional Status and Clinical Outcome in Patients With Gastrointestinal Stromal Tumor After Surgical Resection

Overview
Journal Front Nutr
Date 2022 Feb 21
PMID 35187038
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Currently, gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors in the gastrointestinal tract, and surgical resection is the main treatment. Malnutrition after gastrointestinal surgery is not uncommon, which may have adverse effects on postoperative recovery and prognosis. However, the nutritional status of GIST patients after surgical resection and its impact on clinical outcomes have received less attention. Therefore, the aim of this study was to dynamically evaluate the nutritional status of GIST patients undergoing surgical resection, and to analyze the correlation between nutritional status and clinical outcomes.

Methods: We retrospectively analyzed the clinical data of GIST patients who underwent surgical resection in the Fourth Hospital of Hebei Medical University from January 2016 to January 2020. Nutritional risk screening 2002 (NRS2002) and Patient-Generated Subjective Global Assessment (PG-SGA) were used to assess the nutritional status of all patients at admission and discharge, and the correlation between nutritional risk and clinical outcomes was analyzed.

Results: A total of 413 GIST patients were included in this study, among which 114 patients had malnutrition risk at admission (NRS2002 score ≥ 3), and 65 patients had malnutrition (PG-SGA score ≥ 4). The malnutrition risk rate (27.60 vs. 46.73%, < 0.001) and malnutrition incidence (15.73 vs. 37.29%, < 0.001) at admission were lower than those at discharge. Compared with the laboratory results at admission, the albumin, prealbumin, and total protein of the patients at discharge were significantly lower (all < 0.05). And there was a negative correlation between PG-SGA and clinical outcome (all < 0.05).

Conclusion: The nutritional status of GIST patients after surgical resection at discharge was worse than that at admission, and malnutrition is an important risk factor leading to poor clinical outcomes.

Citing Articles

NRS2002 score as a prognostic factor in solid tumors treated with immune checkpoint inhibitor therapy: a real-world evidence analysis.

Tang W, Li C, Huang D, Zhou S, Zheng H, Wang Q Cancer Biol Ther. 2024; 25(1):2358551.

PMID: 38813753 PMC: 11141475. DOI: 10.1080/15384047.2024.2358551.


Examining the impact of early enteral nutritional support on postoperative recovery in patients undergoing surgical treatment for gastrointestinal neoplasms.

Chen Z, Hong B, He J, Ye Q, Hu Q World J Gastrointest Surg. 2023; 15(10):2222-2233.

PMID: 37969702 PMC: 10642466. DOI: 10.4240/wjgs.v15.i10.2222.


Inflammation and nutritional status indicators as prognostic indicators for patients with locally advanced gastrointestinal stromal tumors treated with neoadjuvant imatinib.

Ding P, Wu J, Wu H, Sun C, Guo H, Lowe S BMC Gastroenterol. 2023; 23(1):23.

PMID: 36690935 PMC: 9869595. DOI: 10.1186/s12876-023-02658-x.


Prognostic Nomogram for Gastrointestinal Stromal Tumors after Surgery Based on the SEER Database.

Sun Q, Chen Y, Li T, Zhu X, Zhu G, Ni B Biomed Res Int. 2022; 2022:5639174.

PMID: 36420093 PMC: 9678471. DOI: 10.1155/2022/5639174.


Serum creatinine/cystatin C ratio is a systemic marker of sarcopenia in patients with gastrointestinal stromal tumours.

Ding P, Guo H, Sun C, Chen S, Yang P, Tian Y Front Nutr. 2022; 9:963265.

PMID: 36118766 PMC: 9478187. DOI: 10.3389/fnut.2022.963265.

References
1.
Yu K, Zhou X, He S . A multicentre study to implement nutritional risk screening and evaluate clinical outcome and quality of life in patients with cancer. Eur J Clin Nutr. 2013; 67(7):732-7. DOI: 10.1038/ejcn.2013.81. View

2.
Sun H, Zhang L, Zhang P, Yu J, Kang W, Guo S . A comprehensive nutritional survey of hospitalized patients: Results from nutritionDay 2016 in China. PLoS One. 2018; 13(3):e0194312. PMC: 5863998. DOI: 10.1371/journal.pone.0194312. View

3.
Lis C, Gupta D, Lammersfeld C, Markman M, Vashi P . Role of nutritional status in predicting quality of life outcomes in cancer--a systematic review of the epidemiological literature. Nutr J. 2012; 11:27. PMC: 3408376. DOI: 10.1186/1475-2891-11-27. View

4.
Kobayashi D, Ishigure K, Mochizuki Y, Nakayama H, Sakai M, Ito S . Multi-institutional prospective feasibility study to explore tolerability and efficacy of oral nutritional supplements for patients with gastric cancer undergoing gastrectomy (CCOG1301). Gastric Cancer. 2016; 20(4):718-727. DOI: 10.1007/s10120-016-0668-3. View

5.
Laky B, Janda M, Kondalsamy-Chennakesavan S, Cleghorn G, Obermair A . Pretreatment malnutrition and quality of life - association with prolonged length of hospital stay among patients with gynecological cancer: a cohort study. BMC Cancer. 2010; 10:232. PMC: 2894793. DOI: 10.1186/1471-2407-10-232. View